Paul Sachs

Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2–4 COPD: results from two replicate 48-week studies

Gary T. Ferguson, Gregory Feldman, Peter Hofbauer et al. · International Journal of COPD · 2014 · 71 citations · Full text

One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2–4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis

Lorcan McGarvey, Dennis E. Niewoehner, Sheldon Magder et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2015 · 35 citations · Full text

Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis

Emily C. O’Brien, Anne S. Hellkamp, Megan L. Neely et al. · CHEST Journal · 2020 · 35 citations · Full text

Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis

Brigitta U. Monz, Paul Sachs, Jeffrey G. McDonald et al. · Respiratory Medicine · 2009 · 32 citations

Asthma, Pulmonary Care, Advanced Lung Disease +6

Is the EQ-5D responsive to recovery from a moderate COPD exacerbation?

Lucas Goossens, Michael C. Nivens, Paul Sachs et al. · Respiratory Medicine · 2011 · 27 citations · Full text

Eq-5d Responsive, Rehabilitation, Moderate Copd Exacerbation